-transparent.png){kind=logo}
The biological half-life of synthetic, radiochemically pure, biologically active [3H]1-deamino-8-D-arginine-vasopressin (dDAVP) in rats was found to be 5.33 +/- 0.28 (S.E.M.) min in the initial, transitional, fast phase and 56.28 +/- 3.27 min in the second, slow phase. The substance accumulated to the greatest extent in the kidney and small intestine and only slightly in the adenohypophysis. The results have suggested that the extended biological half-life may play a role in the more marked and longer antidiuretic effect of dDAVP. The explanation of the poor accumulation in the adenohypophysis may be that dDAVP does not possess an effect similar to that of corticotrophin releasing factor.
F A László, and
T Janáky, and
L Baláspiri, and
J L Morgat
March 1980,
Orvosi hetilap,
F A László, and
T Janáky, and
L Baláspiri, and
J L Morgat
June 1976,
Journal of medicinal chemistry,
F A László, and
T Janáky, and
L Baláspiri, and
J L Morgat
February 1985,
Acta endocrinologica,
F A László, and
T Janáky, and
L Baláspiri, and
J L Morgat
January 1975,
Acta medica Academiae Scientiarum Hungaricae,
F A László, and
T Janáky, and
L Baláspiri, and
J L Morgat
January 1974,
The Journal of pharmacology and experimental therapeutics,
F A László, and
T Janáky, and
L Baláspiri, and
J L Morgat
September 1980,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
F A László, and
T Janáky, and
L Baláspiri, and
J L Morgat
April 1976,
International journal of clinical pharmacology and biopharmacy,
F A László, and
T Janáky, and
L Baláspiri, and
J L Morgat
January 1989,
Nephron,
F A László, and
T Janáky, and
L Baláspiri, and
J L Morgat
January 1994,
Haemostasis,
F A László, and
T Janáky, and
L Baláspiri, and
J L Morgat
August 1985,
Endocrinologia japonica,
